{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:43:03Z","timestamp":1790390583564,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,9,23]],"date-time":"2017-09-23T00:00:00Z","timestamp":1506124800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s10067-017-3845-9","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T23:00:23Z","timestamp":1506121223000},"page":"749-756","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud\u2019s phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathway"],"prefix":"10.1007","volume":"37","author":[{"given":"Chieh-Yu","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko-Jen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Hsuan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song-Chou","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,23]]},"reference":[{"issue":"6","key":"3845_CR1","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/01.bor.0000138677.88694.a4","volume":"16","author":"BM Kahaleh","year":"2004","unstructured":"Kahaleh BM (2004) Raynaud phenomenon and the vascular disease in scleroderma. Curr Opin Rheumatol 16(6):718\u2013722","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"3845_CR2","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s00281-015-0505-5","volume":"37","author":"Y Asano","year":"2015","unstructured":"Asano Y, Sato S (2015) Vasculopathy in scleroderma. Semin Immunopathol 37(5):490\u2013500","journal-title":"Semin Immunopathol"},{"issue":"8","key":"3845_CR3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrrheum.2012.96","volume":"8","author":"AL Herick","year":"2012","unstructured":"Herick AL (2012) The pathogenesis, diagnosis and treatment of Raynaud phenomenon. Nat Rev Rheumatol 8(8):469\u2013479","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"3845_CR4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/art.1780340111","volume":"34","author":"ES Weiner","year":"1991","unstructured":"Weiner ES, Hildebrandt S, Senecal J-L, Daniels L, Noell S, Joyal F, Roussin A, Earnshaw W, Rathfield NF (1991) Prognostic significance of anti-centromere antibodies and anti-topoisomerase 1 antibodies in Raynaud\u2019s disease\u2014a prospective study. Arthritis Rheum 34(1):68\u201377","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3845_CR5","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.coi.2007.11.004","volume":"19","author":"A Gabrielli","year":"2007","unstructured":"Gabrielli A, Svegliati S, Moroncini G, Avvedimento EV (2007) Pathogenic autoantibodies in systemic sclerosis. Curr Opin Immunol 19(6):640\u2013645","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"3845_CR6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrrheum.2009.238","volume":"6","author":"SI Nihtyanova","year":"2010","unstructured":"Nihtyanova SI, Denton CP (2010) Autoantibodies as predictive tools in systemic sclerosis. Nat Rev Rheumatol 6(2):112\u2013116","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"3845_CR7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1346-8138.2009.00762.x","volume":"37","author":"Y Hamaguchi","year":"2010","unstructured":"Hamaguchi Y (2010) Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluations and prognosis. J Dermatol 37(1):42\u201353","journal-title":"J Dermatol"},{"issue":"3","key":"3845_CR8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12016-012-8331-1","volume":"43","author":"P Moinzadeh","year":"2012","unstructured":"Moinzadeh P, Nihtyanova SI, Howell K, Ong VH, Denton CP (2012) Impact of hallmark autoantibody reactivity on early diagnosis in scleroderma. Clin Rev Allergy Immunol 43(3):249\u2013255","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"3845_CR9","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/BOR.0000000000000325","volume":"28","author":"MY Choi","year":"2016","unstructured":"Choi MY, Fritzler MJ (2016) Progress in understanding the diagnostic and pathogenic role of autoantibodies associated with systemic sclerosis. Curr Opin Rheumatol 28(6):586\u2013594","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"3845_CR10","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/rheumatology\/keh156","volume":"43","author":"M Cutolo","year":"2004","unstructured":"Cutolo M, Piggorni C, Tuccio M, Burroni A, Craviotto C, Basso M, Seriolo B, Sulli A (2004) Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology 43(6):719\u2013726","journal-title":"Rheumatology"},{"issue":"3","key":"3845_CR11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3109\/03009742.2013.847118","volume":"43","author":"O Schlager","year":"2014","unstructured":"Schlager O, Kiener HP, Stein L, Hofkirchner J, Zehetmayer S, Ristl R, Perkmann T, Smolen JS, Koppensteiner R, Gachwandtner ME (2014) Associations of nailfold abnormalities and immunological markers in early Raynaud\u2019s phenomenon. Scand J Rheumatol 43(3):226\u2013233","journal-title":"Scand J Rheumatol"},{"issue":"10","key":"3845_CR12","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1172\/JCI2261","volume":"101","author":"A Bordron","year":"1998","unstructured":"Bordron A, Dueymes M, Levy Y, Jamin C, Leroy JP, Piette JC, Shoenfeld Y, Youinou PY (1998) The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis. J Clin Invest 101(10):2029\u20132035","journal-title":"J Clin Invest"},{"issue":"11","key":"3845_CR13","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H","volume":"43","author":"R Sgonc","year":"2000","unstructured":"Sgonc R, Gruschwitz MS, Boeck G, Sepp N, Gruber J, Wick G (2000) Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95. Arthritis Rheum 43(11):2550\u20132562","journal-title":"Arthritis Rheum"},{"issue":"7","key":"3845_CR14","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1002\/art.21952","volume":"54","author":"SS Ahmed","year":"2006","unstructured":"Ahmed SS, Tan KF, Arnett FC, Lin L, Gerg Y-J (2006) Induction of apoptosis and fibrillin I expression in human dermal endothelial cell by scleroderma sera containing anti-endothelial cell antibodies. Arthritis Rheum 54(7):2250\u20132262","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3845_CR15","first-page":"1244","volume":"30","author":"G Porceillo","year":"2003","unstructured":"Porceillo G, Scarpato R, Ferric C, Storino F, Cagetti F, Morozzi G, Bellisai F, Migliore L, Marcolongo R, Galeazzi M (2003) Spontaneous chromosome damage (micronuclei) in systemic sclerosis and Raynaud\u2019s phenomenon. J Rheumatol 30(6):1244\u20131247","journal-title":"J Rheumatol"},{"issue":"12","key":"3845_CR16","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1002\/art.24038","volume":"58","author":"M Kaenig","year":"2008","unstructured":"Kaenig M, Joyal F, Fritzler M, Roussin A, Abrahamowicg M, Boire G, Goulet J-R, Rich E, Grodzicky T, Kaymond Y, Senecal J-L (2008) Autoantibodies and microvascular damage and independent predictive factors for the progression of Raynaud\u2019s phenomenon to systemic sclerosis. Arthritis Rheum 58(12):3902\u20133912","journal-title":"Arthritis Rheum"},{"issue":"5","key":"3845_CR17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11926-015-0505-4","volume":"17","author":"A Kill","year":"2015","unstructured":"Kill A, Riemekasten G (2015) Functional autoantibodies in systemic sclerosis pathogenesis. Curr Rheumatol Rep 17(5):34\u201339","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"3845_CR18","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Fleischmaier R, Jablonoka S, Krieg T, Medsger TA Jr, Rowell N, Wallheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202\u2013205","journal-title":"J Rheumatol"},{"key":"3845_CR19","doi-asserted-by":"publisher","unstructured":"Ntelis K, Solomou EE, Sakkas L, Loissis SN, Daoussis D (2017) The role of platelets in autoimmunity, vasculopathy, and fibrosis: implications for systemic sclerosis. Sem Arthritis Rheum. \nhttps:\/\/doi.org\/10.1016\/j.semarthrit.2017.05.004","DOI":"10.1016\/j.semarthrit.2017.05.004"},{"issue":"5","key":"3845_CR20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/rheumatology\/keh552","volume":"44","author":"AL Herrick","year":"2005","unstructured":"Herrick AL (2005) Pathogenesis of Raynaud\u2019s phenomenon. Rheumatology 44(5):587\u2013596","journal-title":"Rheumatology"},{"issue":"7","key":"3845_CR21","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/1744666X.2017.1279052","volume":"13","author":"AL Herrick","year":"2017","unstructured":"Herrick AL (2017) Therapeutic implications from the pathogenesis of Raynaud\u2019s phenomenon. Expert Rev Clin Immunol 13(7):723\u2013735","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"3845_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.1780380102","volume":"38","author":"BM Kahaleh","year":"1995","unstructured":"Kahaleh BM, Matucci-Cerinic M (1995) Raynaud\u2019s phenomenon and scleroderma. Dysregulated neuroendothelial control of vascular tone. Arthritis Rheum 38(1):1\u20134","journal-title":"Arthritis Rheum"},{"issue":"11","key":"3845_CR23","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s11033-016-4065-0","volume":"43","author":"MY Teizi","year":"2016","unstructured":"Teizi MY, Izmirli M, Gogebakan B (2016) The cell fate: senescence or quiescence. Mol Biol Rep 43(11):1213\u20131220","journal-title":"Mol Biol Rep"},{"issue":"11","key":"3845_CR24","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/cas.13060","volume":"107","author":"Y Johmura","year":"2016","unstructured":"Johmura Y, Nakanishi M (2016) Multiple facets of p53 in senescence induction and maintenance. Cancer Sci 107(11):1550\u20131555","journal-title":"Cancer Sci"},{"issue":"8","key":"3845_CR25","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/ard.53.8.540","volume":"53","author":"AL Herrick","year":"1994","unstructured":"Herrick AL, Meaney M, Hollis S, Jaysen MIV (1994) Anti-cardiolipin, anti-centromere and anti-Scl-70 antibodies in patients with systemic sclerosis and severe digital ischemia. Ann Rheum Dis 53(8):540\u2013542","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3845_CR26","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1034\/j.1399-3038.2000.00066.x","volume":"11","author":"E Hossny","year":"2000","unstructured":"Hossny E, Abdul Hady H, Mabrouk R (2000) Anti-centromere antibodies as a marker of Raynaud\u2019s phenomenon in pediatric rheumatologic disease. Pediatr Allergy Immunol 11(4):250\u2013255","journal-title":"Pediatr Allergy Immunol"},{"issue":"8","key":"3845_CR27","first-page":"1488","volume":"32","author":"S Miyawaki","year":"2005","unstructured":"Miyawaki S, Asanuma H, Nishiyama S, Yoshinaga Y (2005) Clinical and serological heterogeneity in patients with anticentromere antibodies. J Rheumatol 32(8):1488\u20131494","journal-title":"J Rheumatol"},{"issue":"3","key":"3845_CR28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/rheumatology\/28.3.221","volume":"28","author":"RRC Buchanan","year":"2009","unstructured":"Buchanan RRC, Riglar AG (2009) The titer of anti-centromere antibodies: its relationship to Raynaud\u2019s phenomenon and vascular occlusion. Rheumatology 28(3):221\u2013226","journal-title":"Rheumatology"},{"issue":"3","key":"3845_CR29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2230.2007.02678.x","volume":"33","author":"K Komura","year":"2008","unstructured":"Komura K, Yanaba K, Ogawa F, Schimizu K, Takehara K, Sato S (2008) Elevation of IgG levels is a serological indicator for pulmonary fibrosis in systemic sclerosis with anti-topoisomerase I antibodies and those with anti-centromere antibody. Clin Exp Dermatol 33(3):329\u2013332","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"3845_CR30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.clim.2004.01.005","volume":"111","author":"P Garcia de la Pena-Lefebvre","year":"2004","unstructured":"Garcia de la Pena-Lefebvre P, Chanseaud Y, Tomby MC, Reinbolt J, Batteux F, Allanore Y, Kahan A, Meyer O, Benveniste O, Boyer O, Guillevin L, Boissier M-C, Mouthon L (2004) IgG reactivity with a 100-kDa tissue and endothelial cell antigen identified as topoisomerase-1 distinguishes between limited and diffuse systemic sclerosis patients. Clin Immunol 111(3):241\u2013251","journal-title":"Clin Immunol"},{"issue":"10","key":"3845_CR31","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.3899\/jrheum.091346","volume":"37","author":"N Papa Del","year":"2010","unstructured":"Del Papa N, Quirici N, Scavullo C, Gianelli U, Corti L, Vitali C, Ferri C, Giuggiolu D, Manfredi A, Maglione W, Onida F, Colaci M, Bosari S, Lambertenghi Deliliers G (2010) Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis. J Rheumatol 37(10):2053\u20132063","journal-title":"J Rheumatol"},{"issue":"2","key":"3845_CR32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/ard.2008.102400","volume":"69","author":"C Mihai","year":"2010","unstructured":"Mihai C, Tervaert JWC (2010) Anti-endothelial antibodies in systemic sclerosis. Ann Rheum Dis 69(2):319\u2013324","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"3845_CR33","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/thx.2004.029082","volume":"60","author":"MC Tamby","year":"2005","unstructured":"Tamby MC, Chanseaud Y, Humbert M, Fermanian J, Guilpain P, Garcia de la Pena-Lefebvre P, Brunet S, Servethaz A, Weill B (2005) Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension. Thorax 60(9):765\u2013772","journal-title":"Thorax"},{"issue":"2","key":"3845_CR34","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.clim.2006.02.006","volume":"120","author":"A Servettaz","year":"2006","unstructured":"Servettaz A, Tamby MC, Guilpan P, Reinbolt J, Garcia de la Pena-Lefebvre P, Allanore Y, Kahan A, Meyer O, Guillevin L, Mouthon L (2006) Anti-endothelial cell antibodies from patients with limited cutaneous systemic sclerosis bind to centromeric protein B (CENP-B). Clin Immunol 120(2):212\u2013219","journal-title":"Clin Immunol"},{"issue":"4","key":"3845_CR35","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/03009740801978871","volume":"37","author":"C Kampolis","year":"2008","unstructured":"Kampolis C, Plastiras SC, Vlachoyiannopoulos PG, Moyssakis I, Tzelepis GE (2008) The presence of anti-centromere antibodies may predict progression of estimated pulmonary arterial systemic pressure in systemic sclerosis. Scand J Rheumatol 37(4):278\u2013283","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"3845_CR36","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1006\/clim.1998.4643","volume":"90","author":"D Vazquez-Abad","year":"1999","unstructured":"Vazquez-Abad D, Grodzieky T, Senecal J-L (1999) Anticentromere autoantibodies in patients without Raynaud\u2019s disease or systemic sclerosis. Clin Immunol 90(2):182\u2013189","journal-title":"Clin Immunol"},{"issue":"10","key":"3845_CR37","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1002\/art.20515","volume":"50","author":"J Henault","year":"2004","unstructured":"Henault J, Tremblay M, Clement I, Raymond Y, Senecal J-L (2004) Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis. Arthritis Rheum 50(10):3265\u20133274","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3845_CR38","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/art.21646","volume":"54","author":"J Henault","year":"2006","unstructured":"Henault J, Robitaille G, Senecal J-L, Raymond Y (2006) DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients. Arthritis Rheum 54(3):963\u2013973","journal-title":"Arthritis Rheum"},{"issue":"7","key":"3845_CR39","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/art.23486","volume":"58","author":"D Kim","year":"2008","unstructured":"Kim D, Peck A, Santer D, Patole P, Schuartz SM, Molitor JA, Arnett FC, Elkon KB (2008) Induction of interferon-\u03b1 by scleroderma sera containing autoantibodies to topoisomerase-I. Arthritis Rheum 58(7):2163\u20132173","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3845_CR40","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/jcp.20919","volume":"210","author":"H Zhang","year":"2006","unstructured":"Zhang H (2006) Molecular signaling and genetic pathways of senescence: its role in tumorigenesis and aging. J Cell Physiol 210(3):567\u2013574","journal-title":"J Cell Physiol"},{"key":"3845_CR41","unstructured":"Pandey JK, Dash SK, Biswal B (2017) Loss of photosynthesis during senescence is accomplished by an increase in the activity of \u03b2-galactosidase in leaves of Arabidopsis thaliana: modulation of the enzyme activity by water stress. Proroplasma\u00a0254(4):1651\u20131659"},{"key":"3845_CR42","doi-asserted-by":"crossref","unstructured":"Chen J, Wang A, Chen Q (2017) SirT3 and p53 deacetylation in aging and cancer. J Cell Physiol 232(9):2308\u20132311","DOI":"10.1002\/jcp.25669"},{"key":"3845_CR43","doi-asserted-by":"crossref","first-page":"ID2019498","DOI":"10.1155\/2016\/2019498","volume":"2016","author":"J Savickiene","year":"2016","unstructured":"Savickiene J, Baronaite S, Zentelyte A, Treigyte G, Navakauskiene R (2016) Senescence-associated molecular and epigenetic alterations in mesenchymal stem cell cultures from amniotic fluid of normal and fetus-affected pregnancy. Stem Cells Int 2016:ID2019498","journal-title":"Stem Cells Int"},{"issue":"12","key":"3845_CR44","first-page":"151","volume":"7","author":"U Degirmenci","year":"2016","unstructured":"Degirmenci U, Lei S (2016) Role of lncRNAs in cellular aging. Front Endocrinol 7(12):151\u2013160","journal-title":"Front Endocrinol"},{"issue":"5","key":"3845_CR45","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/acel.12242","volume":"13","author":"SN Mowla","year":"2014","unstructured":"Mowla SN, Lam EW-F, Jat PS (2014) Cellular senescence and aging: the role of B-MYB. Aging Cell 13(5):773\u2013779","journal-title":"Aging Cell"},{"issue":"13","key":"3845_CR46","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1080\/15384101.2016.1152433","volume":"15","author":"CC Feng","year":"2016","unstructured":"Feng CC, Liu H, Yang MH, Zhang Y, Huang B, Zhou Y (2016) Disc cell senescence in intervertebral disc degeneration: causes and molecular pathways. Cell Cycle 15(13):1674\u20131684","journal-title":"Cell Cycle"},{"issue":"3","key":"3845_CR47","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.joca.2015.09.019","volume":"24","author":"F Wang","year":"2016","unstructured":"Wang F, Cai F, Wang X-H, Wu X-T (2016) Aging and age-related stresses: a senescence mechanism of intervertebral disc degeneration. Osteoarthr Cartil 24(3):398\u2013408","journal-title":"Osteoarthr Cartil"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-017-3845-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3845-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3845-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,3]],"date-time":"2018-03-03T04:21:25Z","timestamp":1520050885000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-017-3845-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,23]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["3845"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3845-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,23]]}}}